Oxford Nanopore secures Fed Circ victory in PacBio DNA suit

13-05-2021

Muireann Bolger

Oxford Nanopore secures Fed Circ victory in PacBio DNA suit

rafapress / Shutterstock.com

The US Court of Appeals for the Federal Circuit has upheld a district court jury decision that found Pacific Biosciences’ DNA sequencing patents—which it had asserted against Oxford Nanopore Technologies—were invalid.


Federal Circuit, Pacific Biosciences, Oxford Nanopore Technologies

LSIPR